Skip to main content
. 2002 Jul 1;99(14):9433–9438. doi: 10.1073/pnas.122612899

Figure 3.

Figure 3

Distribution of APC, K-ras, and p53 mutations in patients with colorectal cancer. The presence of mutations in APC, K-ras, and p53 was determined in a cohort of patients with colorectal cancer (n = 106) by a combination of WAVE denaturing HPLC analysis and direct sequencing, as described in Materials and Methods. The percentage of tumors with each combination of mutations is illustrated.